GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Total Assets

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Total Assets : ¥11,051 Mil (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Total Assets?

Tianjin Pharmaceutical Da Ren Tang Group's Total Assets for the quarter that ended in Mar. 2024 was ¥11,051 Mil.

Warning Sign:

If a company builds assets at 7% a year, faster than its revenue growth rate of 5.3% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Tianjin Pharmaceutical Da Ren Tang Group's average Total Assets Growth Rate was 15.90% per year. During the past 3 years, the average Total Assets Growth Rate was 8.80% per year. During the past 5 years, the average Total Assets Growth Rate was 7.00% per year. During the past 10 years, the average Total Assets Growth Rate was 5.40% per year.

During the past 13 years, Tianjin Pharmaceutical Da Ren Tang Group's highest 3-Year average Total Assets Growth Rate was 31.80%. The lowest was -5.40%. And the median was 6.60%.

Total Assets is connected with ROA %. Tianjin Pharmaceutical Da Ren Tang Group's annualized ROA % for the quarter that ended in Mar. 2024 was 14.56%. Total Assets is also linked to Revenue through Asset Turnover. Tianjin Pharmaceutical Da Ren Tang Group's Asset Turnover for the quarter that ended in Mar. 2024 was 0.20.


Tianjin Pharmaceutical Da Ren Tang Group Total Assets Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Total Assets Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,843.18 8,283.39 9,067.09 10,156.98 10,230.10

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,866.53 10,364.01 10,281.70 10,230.10 11,050.62

Tianjin Pharmaceutical Da Ren Tang Group Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Tianjin Pharmaceutical Da Ren Tang Group's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=6645.237+3584.864
=10,230

Tianjin Pharmaceutical Da Ren Tang Group's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=7027.727+4022.895
=11,051

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianjin Pharmaceutical Da Ren Tang Group  (SHSE:600329) Total Assets Explanation

Total Assets is connected with ROA %.

Tianjin Pharmaceutical Da Ren Tang Group's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1549.304/( (10230.101+11050.623)/ 2 )
=1549.304/10640.362
=14.56 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Tianjin Pharmaceutical Da Ren Tang Group's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=2085.588/( (10230.101+11050.623)/ 2 )
=2085.588/10640.362
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Tianjin Pharmaceutical Da Ren Tang Group Total Assets Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines